Draxis, Mylan Laboratories deal

DRAXF acquired exclusive Canadian rights to market Mylan's paclitaxel

Read the full 92 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE